STOCK TITAN

Axonex AI authorizes unlimited shares in both classes

The revised articles replace the 112,000,000-share ceiling with unlimited authorization for both ordinary-share classes.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

Axonex AI Group Ltd (AXNX) changed its maximum authorized share count from 112,000,000 shares—100,800,000 Class A ordinary shares and 11,200,000 Class B ordinary shares—to an unlimited number of each class. The board approved the change on November 3, 2026, and the amended memorandum and articles of association became effective on November 4, 2026.

Maximum authorized shares before amendment 112,000,000 shares Before the change
Class A ordinary shares 100,800,000 shares Authorized before the change
Class B ordinary shares 11,200,000 shares Authorized before the change
maximum number of shares the Company is authorized to issue regulatory
"change of the maximum number of shares the Company is authorized to issue"
Class A ordinary shares technical
"100,800,000 Class A ordinary shares"
Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.
Class B ordinary shares technical
"11,200,000 Class B ordinary shares"
Class B ordinary shares are a type of ownership stake in a company that typically come with different voting rights or privileges compared to other share classes. For investors, they represent a way to hold part of the company’s value and influence its decisions, often with fewer voting rights than Class A shares. Understanding these shares helps investors assess their level of control and potential returns within a company.
memorandum and articles of association regulatory
"sixth amended and restated memorandum and articles of association"
Memorandum and articles of association are the founding legal documents of a company: the memorandum sets out the company’s basic purpose and scope, while the articles act as its internal rulebook detailing how the company is run, who has what powers, and how decisions are made. For investors these documents matter because they define ownership rights, voting rules, limits on activities, and procedures for major changes—like a contract and rulebook that determine how their investment can be used and protected.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares is AXNX authorized to issue after the amendment?

AXNX is authorized to issue an unlimited number of Class A ordinary shares and an unlimited number of Class B ordinary shares. Before the change, the maximum was 112,000,000 shares, divided into 100,800,000 Class A ordinary shares and 11,200,000 Class B ordinary shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2026

 

Commission File Number: 001-42462

 

Axonex AI Group Limited

 

Unit 506-8, 5/F, Laford Centre

838 Lai Chi Kok Road

Lai Chi Kok, Kowloon, Hong Kong

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

 

 

 

 

 

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

 

Change of Authorized Shares 

 

On November 3, 2026, the Board of Directors of Axonex AI Group Limited, a British Virgin Islands business company (the “Company”), approved, by unanimous written resolutions of directors, a change of the maximum number of shares the Company is authorized to issue. The maximum changes from 112,000,000 shares of no par value, divided into 100,800,000 Class A ordinary shares and 11,200,000 Class B ordinary shares, to an unlimited number of shares of no par value, divided into an unlimited number of Class A ordinary shares and an unlimited number of Class B ordinary shares. The board also adopted a sixth amended and restated memorandum and articles of association of the Company reflecting only this change (the “Sixth Amended M&A”). The Sixth Amended M&A was filed with the Registrar of Corporate Affairs of the British Virgin Islands and became effective on November 4, 2026. A copy of the Sixth Amended M&A is attached hereto as Exhibit 3.1. 

 

This Report is incorporated by reference into the Company’s registration statement on Form F-3, as amended, filed with the Securities and Exchange Commission on May 19, 2026 (File No. 333-296027) and shall be deemed to be a part thereof from the date on which this Report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.  

 

1

 

 

Exhibit Index

 

Exhibit
Number
  Description of Exhibit
3.1   Sixth Amended and Restated Memorandum and Articles of Association

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: November 5, 2026 Axonex AI Group Limited
     
  By: /s/ Hoi Lung Chan
  Name:  Hoi Lung Chan
  Title: Chief Executive Officer and Chairman of the Board

 

3

 

 

Filing Exhibits & Attachments

1 document

Keep reading